Latest Aggregates News

Anax Metals Limited has secured a strategic $2.4 million placement and a $3.5 million loan, reinforcing its development plans for the Whim Creek Project in Western Australia's Pilbara region. The company is progressing its feasibility study update, due in March 2026, while advancing partnerships and funding strategies.

Global Uranium and Enrichment Limited has finalised the share and option scheme considerations for its acquisition by Snow Lake Resources, with directors backing the deal ahead of the upcoming shareholder vote.

Anteris Technologies has completed a $90 million strategic investment from Medtronic as part of a $320 million capital raise, advancing its DurAVR transcatheter heart valve towards global commercialisation and pivotal clinical trials.

Venus Metals Corporation progresses its Sandstone Bellchambers gold project with a new mining lease and exploration targets, while extending its Bridgetown JV farm-in and navigating an unsolicited takeover offer.

NH3 Clean Energy has marked significant progress in its WAH2 clean ammonia project, securing major offtake agreements and government facilitation support alongside a $4 million institutional funding round.

VRX Silica Limited has locked in six binding offtake contracts totaling nearly 1 million tonnes per annum and appointed a new CEO, marking significant progress for its Arrowsmith North silica sand project.

Fletcher Building’s Q2 FY26 volumes edged up modestly from the previous quarter, buoyed by gains in light building products, while heavy materials continued to decline amid ongoing margin pressures.

IAG has integrated RACQ Insurance into its core reinsurance programs, expanding catastrophe coverage and boosting downside protection through to 2029. This move aims to stabilise earnings and unlock synergies following RACQ’s acquisition.

Renergen Limited and Asp Isotopes Inc. have outlined the process for cash payments to shareholders for fractional entitlements following their share acquisition scheme.

Neurizon Therapeutics has progressed its ALS treatment NUZ-001 into critical clinical trial phases, even as the FDA declines its Fast Track Designation request pending more data.

BPH Global reported a seasonal dip in December revenue due to rainy conditions affecting seaweed supply, yet maintains strong growth momentum with A$1.77 million gross revenue over seven months.

JAYRIDE Group has amended its quarterly cash flow report to correct classification errors, while outlining plans for a new SaaS platform rollout and potential capital raising to support operations.